Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Open access and online dissemination of cancer research
Prof Umberto Veronesi - Director of the European Institute of Oncology, Milan
Open access and online dissemination of cancer research ( Prof Umberto Veronesi - Director of the European Institute of Oncology, Milan )
18 Mar 2009
Hadron therapy
Prof Roberto Orecchia - Director of Radiation Department, European Institute of ...
Hadron therapy ( Prof Roberto Orecchia - Director of Radiation Department, European Institute of Oncology, Milan )
18 Mar 2009
Reductions in breast density predict potential benefit of tamoxifen
Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics...
Reductions in breast density predict potential benefit of tamoxifen ( Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London )
11 Mar 2009
BIG 1-98: Letrozole vs tamoxifen
Dr Alan Coates - School of Public Health, University of Sydney
BIG 1-98: Letrozole vs tamoxifen ( Dr Alan Coates - School of Public Health, University of Sydney )
11 Mar 2009
Continuing adjuvant tamoxifen leads to higher quality of life
Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama...
Continuing adjuvant tamoxifen leads to higher quality of life ( Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan )
11 Mar 2009
New biomarker predicts anthracycline response
Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University
New biomarker predicts anthracycline response ( Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University )
11 Mar 2009
New genetic modelling improves screening for breast cancer
Dr Kathie Dalessandri - Physician Scientist at the University of California, San...
New genetic modelling improves screening for breast cancer ( Dr Kathie Dalessandri - Physician Scientist at the University of California, San Francisco )
11 Mar 2009
Herceptin Increases event-free survival in locally advanced HER2-postive breast ...
Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan
Herceptin Increases event-free survival in locally advanced HER2-postive breast cancer ( Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan )
11 Mar 2009
Zoledronic acid may have anti-tumour properties
Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield
Zoledronic acid may have anti-tumour properties ( Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield )
11 Mar 2009
Hormone supplements reduce death from breast cancer
Sarah Marshall - Epidemiologist, University of California, Irvine
Hormone supplements reduce death from breast cancer ( Sarah Marshall - Epidemiologist, University of California, Irvine )
11 Mar 2009
Breast cancer patients may have better option to reduce oestrogen levels
Dr Stephen Jones - Director of US Oncology Research Inc, Texas
Breast cancer patients may have better option to reduce oestrogen levels ( Dr Stephen Jones - Director of US Oncology Research Inc, Texas )
11 Mar 2009
Use of written forms doubles breast cancer detection rate
Dr William Goodson - Senior Clinical Research Scientist, California Pacific Medi...
Use of written forms doubles breast cancer detection rate ( Dr William Goodson - Senior Clinical Research Scientist, California Pacific Medical Center Research Institute )
11 Mar 2009